Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C

BACKGROUND: Our recent study showed that tetrathiomolybdate (TM), a drug to treat copper overload disorders, can sensitize drug-resistant endometrial cancer cells to reactive oxygen species (ROS)-generating anticancer drug doxorubicin. To expand these findings in the present study we explore TM effi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent, Moore, Richard G
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353246/
https://ncbi.nlm.nih.gov/pubmed/22502731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-147
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky